EP1945532A1 - Secure tablet package - Google Patents

Secure tablet package

Info

Publication number
EP1945532A1
EP1945532A1 EP06830974A EP06830974A EP1945532A1 EP 1945532 A1 EP1945532 A1 EP 1945532A1 EP 06830974 A EP06830974 A EP 06830974A EP 06830974 A EP06830974 A EP 06830974A EP 1945532 A1 EP1945532 A1 EP 1945532A1
Authority
EP
European Patent Office
Prior art keywords
blister
packaging
secure
drugs
case
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
EP06830974A
Other languages
German (de)
French (fr)
Other versions
EP1945532B1 (en
Inventor
Eric Doucet
Corinne Doucet
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ACD
Original Assignee
ACD
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ACD filed Critical ACD
Publication of EP1945532A1 publication Critical patent/EP1945532A1/en
Application granted granted Critical
Publication of EP1945532B1 publication Critical patent/EP1945532B1/en
Not-in-force legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
    • B65D83/00—Containers or packages with special means for dispensing contents
    • B65D83/04—Containers or packages with special means for dispensing contents for dispensing annular, disc-shaped, or spherical or like small articles, e.g. tablets or pills
    • B65D83/0445—Containers or packages with special means for dispensing contents for dispensing annular, disc-shaped, or spherical or like small articles, e.g. tablets or pills all the articles being stored in individual compartments
    • B65D83/0463—Containers or packages with special means for dispensing contents for dispensing annular, disc-shaped, or spherical or like small articles, e.g. tablets or pills all the articles being stored in individual compartments formed in a band or a blisterweb, inserted in a dispensing device or container
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
    • B65D2215/00—Child-proof means
    • B65D2215/02—Child-proof means requiring the combination of simultaneous actions

Definitions

  • the present invention relates to a secure packaging for tablets, and more particularly to a cellular package dispensing pills of the type comprising at least one blister, with a lid.
  • Blister-type blister packs are very widely used packaging, and the tablets under their transparent cells are particularly attractive to children, especially since to have access to them simply press on the tablet to deteriorate the skin. cover.
  • the purpose of the invention is that for the user to take a tablet, there is for him the need to have to perform two simultaneous actions, while access to the tablet is not possible as soon as the one of the shares is not maintained.
  • the user must move the blister to match the blister operculum with the hole of the case, and push on the tablet to eject. If the action on the blister is not maintained, the latter by the action of an elastic system returns to its original position and therefore even if the user persists in exerting an effort on the tablet, the latter can not not be released because prevented by the bottom of the holster.
  • the package of the invention is a secure packaging for medicaments, which is characterized in that it comprises means of condemnation of access to the drug such that to access the drugs the user must perform two simultaneous actions, while that as soon as one of the actions is interrupted access is made impossible.
  • the package consists of a case, a blister and an elastic system, while the blister pack is a pill dispenser that is constituted by a transparent covering comprising at least one cell. closed by a lid, to imprison the medical tablet (12).
  • the case consists of a part that will be called casing on which is hinged a flap, forming cover (6), and which comprises two sidewalks, namely a first sidewalk and a second sidewalk, each sidewalk extending transversely to form a guide for the blister, while the first sidewalk is a retaining enclosure of the elastic system.
  • the wall constituting the bottom of the case comprises at least one hole for the passage of drugs when the blister is in its position giving access to drugs.
  • the blister comprises at least one rigid lower sheet comprising cutouts intended to be facing the cells, to allow the passage of the tablets after deformation of the corresponding cells and tearing of the lid.
  • the blister is mounted movably in the case, and can thus move in translation in the case (2) and by sliding on the bottom to take two positions, namely an initial rest position , according to which the position of the cells (10) does not correspond to and a so-called active position, according to which the cells are a position in correspondence with the holes in the bottom wall, whereas the elastic system is intended to request the blister in direction of the second sidewalk, and more particularly in support against its vertical wall.
  • Figure 1 is a perspective representation of the packaging in the closed position of non-use.
  • Figure 2 is a perspective representation of the packaging in the open position.
  • Figure 3 is an exploded perspective view showing the various components of the package.
  • FIGS. 4, 5, 6 show the blister of the package of the invention
  • Figure 4 is a top view of the blister of the package.
  • Figure 5 is a sectional view along A-A of the package blister.
  • Figure 6 is a bottom view of the blister of the package.
  • Figures 7 and 8 are plan views showing the package in its two positions, its initial rest position ( Figure 7), and its active drug-taking position ( Figure 8).
  • Figures 9, 10, 11 are sectional views showing the package in its two positions, its initial resting position ( Figure 9), and its active drug-taking position ( Figures 10 and 11).
  • the packaging of the invention bearing the general reference (1) consists of a case (2), a blister (3) and an elastic system (4).
  • the case (2) is for example made of cardboard and consists of a part that will be called casing (5) on which is articulated a flap, forming a lid (6).
  • the housing (5) comprises two sidewalks (7, 8), namely a first sidewalk (7) and a second sidewalk (8), each sidewalk extending transversely to form a guide for the blister, while the first sidewalk (7) constitutes a retaining enclosure of the elastic system (4).
  • the blister (3) is an alveolar package dispensing pills. It consists of a transparent covering (9) comprising at least one cell (10) closed by a cover (11), in order to trap the medical tablet (12).
  • the blister (3) is of the type whose transparent covering (9) comprises several cells (10) and for example new cells, namely three rows and three rows of cells.
  • the transparent covering is for example made in known manner and in particular by thermoforming a sheet, for example PVC. It goes without saying that the covering (9) may not be transparent, without departing from the scope of the invention.
  • the blister (3) further comprises a rigid upper sheet (13) for example cardboard, and a rigid lower sheet (14) for example cardboard.
  • Each of the sheets of cardboard comprises cutouts facing the cells.
  • the cuts of the upper sheet (13) allow the passage of the corresponding cells (10) of the transparent covering (9), while the cuts of the lower sheet (14) allow the passage of tablets after deformation of the corresponding cells and tearing operculum (11).
  • the blister could only include the lower sheet (14) without departing from the scope of the invention.
  • the elastic system (4) is intended to urge the blister (3) towards the second sidewalk (8), and more particularly against its vertical wall (15).
  • Said elastic system can be of any type, but according to the embodiment given by way of example it is constituted by a stirrup constituted by a blade made of deformable plastic material, whose two free branches (17a, 17b) are converging . Furthermore there is provided an abutment system (18a, 18b) limiting the elastic pivoting free branches (17a, 17b) thus allowing a perfect positioning of the blister, in the active position for the release of the tablets.
  • the wall constituting the bottom (16) of the case comprises a succession of holes for the passage of the tablets when the blister is in its position giving access to the tablets.
  • the bottom wall (16) has a length (L1) greater than the length (L2) of the blister, and is such that said length (L1) is equal to the length (L2) of the blister plus the length (L4 ), knowing that the length (L4) is slightly greater than the length (L3) which is length of the elastic system in the biased position.
  • the blister (3) is movable and can move in translation in the case (2) and this by sliding on the bottom (16).
  • the blister can take two positions, namely an initial rest position as illustrated in FIGS. 7, according to which the position of the cells (10) does not correspond to and a so-called active position, as illustrated in FIGS. , 10 and 11, wherein the cells are a position in correspondence with the holes (19) of the bottom wall (16).
  • the package according to the invention comprises gripping means (20) for the user to move the blister.
  • These means can be of any kind, such as for example a projection disposed on the top of the blister.
  • These means may also be as illustrated, namely, a hole (20a) formed in the wall of the blister and a corresponding oblong hole (20b) formed on the bottom wall (16) of the case.

Abstract

A secure package (1) for drugs, blocks access to the drugs such that, to gain access to the drugs, the user must execute two simultaneous actions. When one of the actions is interrupted, access is rendered impossible. The secure package includes a case (2), a blister (3), and an elastic biasing system (4). The blister (3) is a cellular card pack for dispensing pills. The blister (3) is mobile and can be moved in translation in the case (2) by being slid on its base wall (16). Thus, the blister can take up two positions, namely an initial rest position, wherein the position of the cells (10) does not correspond to holes (19) formed in the base wall (16) and a so-called active position, wherein the cells (10) are in a position corresponding to the holes (19) in the base wall (16).

Description

EMBALLAGE SECURISE POUR COMPRIME SECURE PACKAGING FOR COMPRESS
La présente invention concerne un emballage sécurisé pour comprimés, et plus particulièrement un emballage alvéolaire de distribution de pilules du type comprenant au moins un blister, avec un opercule.The present invention relates to a secure packaging for tablets, and more particularly to a cellular package dispensing pills of the type comprising at least one blister, with a lid.
Le danger de prendre des médicaments non désiré est très important, surtout pour des jeunes enfants, voir des enfants qui pourraient être attiré par la vue de comprimés certaines fois colorés qui ressemblent à des bonbons. Il y a donc un risque certain à voir des enfants prendre des médicaments qui ne leurs sont pas destinés, surtout quand les emballages sont laissés sans surveillance.The danger of taking unwanted medications is very important, especially for young children, to see children who might be attracted by the sight of some colorful pills that look like sweets. There is therefore a clear risk that children will be taking medications that are not intended for them, especially when the packages are left unattended.
Les emballages alvéolaires de type blister, sont des emballages très largement répandus, et les comprimés sous leurs alvéoles transparentes sont particulièrement attirants pour des enfants, surtout que pour y avoir accès il n'y a qu'à appuyer sur le comprimé pour détériorer l'opercule.Blister-type blister packs are very widely used packaging, and the tablets under their transparent cells are particularly attractive to children, especially since to have access to them simply press on the tablet to deteriorate the skin. cover.
Certains constructeurs ont développé des d'emballages, pour lesquels la prise des comprimés est rendue difficile. Ainsi il existe des emballages, pour lesquels deux actions simultanées sont nécessaires pour obtenir un médicament. Toute fois malgré ce réel progrès ces emballages ne sont pas totalement satisfaisants. En effet dans la plupart des cas l'emballage une fois ouvertes reste ouvert.Some manufacturers have developed packaging, for which taking tablets is difficult. Thus there are packages, for which two simultaneous actions are necessary to obtain a drug. However, despite this real progress, these packaging are not totally satisfactory. Indeed in most cases the packaging once opened remains open.
On connaît par exemple l'emballage divulgué par la demande internationale de brevet publiée sous le numéro WO 2005/049438, selon lequel l'utilisateur doit faire une double action pour l'ouverture, mais une fois ouvertes l'étui reste ouvert et ne se referme pas seul. C'est aussi le cas des piluliers, pour lesquels pour les ouvrir il est nécessaire de pousser sur le bouchon et simultanément de le faire tourner.For example, the package disclosed by the international patent application published under the number WO 2005/049438, according to which the user must perform a double action for the opening, but once open the case remains open and does not close alone. It is also the case of the pilluliers, for which to open them it is necessary to push on the stopper and simultaneously to turn it.
Le but de l'invention est que pour que l'utilisateur puisse prendre un comprimé, il y ait pour le lui nécessité d'avoir à exécuter deux actions simultanées, tandis que l'accès aux comprimé n'est pas possible dès que l'une des actions n'est pas maintenue.The purpose of the invention is that for the user to take a tablet, there is for him the need to have to perform two simultaneous actions, while access to the tablet is not possible as soon as the one of the shares is not maintained.
Ainsi avec l'emballage de l'invention l'utilisateur doit déplacer le blister afin de mettre en correspondance l'opercule du blister avec le trou de l'étui, et ainsi pousser sur le comprimé pour l'éjecter. Si l'action sur le blister n'est pas maintenue, ce dernier par l'action d'un système élastique reprend sa position initiale et de ce fait même si l'utilisateur persiste à exercer un effort sur le comprimé, ce dernier ne peut pas être libéré car empêché par le fond de l'étui.Thus with the package of the invention the user must move the blister to match the blister operculum with the hole of the case, and push on the tablet to eject. If the action on the blister is not maintained, the latter by the action of an elastic system returns to its original position and therefore even if the user persists in exerting an effort on the tablet, the latter can not not be released because prevented by the bottom of the holster.
Ainsi, l'emballage de l'invention est un emballage sécurisé pour médicaments, qui est caractérisé en ce qu'il comprend des moyens de condamnation d'accès au médicament tels que pour accéder aux médicaments l'utilisateur doit exécuter deux actions simultanées, tandis que dès qu'une des actions est interrompue l'accès est rendu impossible.Thus, the package of the invention is a secure packaging for medicaments, which is characterized in that it comprises means of condemnation of access to the drug such that to access the drugs the user must perform two simultaneous actions, while that as soon as one of the actions is interrupted access is made impossible.
Selon des caractéristiques complémentaires, l'emballage est constitué d'un étui, d'un blister et d'un système élastique, tandis que le blister est un emballage alvéolaire de distribution de pilules qui est constitué par un habillage transparent comportant au moins une alvéole fermée par un opercule, afin d'emprisonner le comprimé médical (12).According to additional features, the package consists of a case, a blister and an elastic system, while the blister pack is a pill dispenser that is constituted by a transparent covering comprising at least one cell. closed by a lid, to imprison the medical tablet (12).
Selon d'autres caractéristiques complémentaires, l'étui est constitué d'une partie que l'on appellera boîtier sur lequel est articulé un rabat, formant couvercle (6), et qui comprend deux trottoirs, à savoir un premier trottoir et un deuxième trottoir, chacun des trottoirs s'étendant transversalement pour constituer un guidage pour Ie blister, tandis que le premier trottoir constitue une enceinte de retenue du système élastique.According to other complementary features, the case consists of a part that will be called casing on which is hinged a flap, forming cover (6), and which comprises two sidewalks, namely a first sidewalk and a second sidewalk, each sidewalk extending transversely to form a guide for the blister, while the first sidewalk is a retaining enclosure of the elastic system.
On notera que la paroi constituant le fond de l'étui, comprend au moins un trou permettant le passage des médicaments quand le blister est dans sa position donnant accès aux médicaments.Note that the wall constituting the bottom of the case, comprises at least one hole for the passage of drugs when the blister is in its position giving access to drugs.
Ajoutons que le blister comprend au moins une feuille inférieure rigide comprenant des découpes destinées à être en regard des alvéoles, afin de permettre le passage des comprimés après déformation des alvéoles correspondantes et déchirement de l'opercule.Add that the blister comprises at least one rigid lower sheet comprising cutouts intended to be facing the cells, to allow the passage of the tablets after deformation of the corresponding cells and tearing of the lid.
Selon d'autres caractéristiques complémentaires, le blister est monté mobile dans l'étui, et peut ainsi se déplacer en translation dans l'étui (2) et ce par coulissement sur le fond pour prendre deux positions, à savoir une position initiale de repos, selon laquelle la position des alvéoles (10) ne correspond pas aux et une position dite active, selon laquelle les alvéoles sont une position en correspondance avec les trous de la paroi de fond, tandis que le système élastique est destiné à solliciter le blister en direction du deuxième trottoir, et plus particulièrement en appui contre sa paroi verticale.According to other complementary features, the blister is mounted movably in the case, and can thus move in translation in the case (2) and by sliding on the bottom to take two positions, namely an initial rest position , according to which the position of the cells (10) does not correspond to and a so-called active position, according to which the cells are a position in correspondence with the holes in the bottom wall, whereas the elastic system is intended to request the blister in direction of the second sidewalk, and more particularly in support against its vertical wall.
D'autres caractéristiques et avantages de l'invention se dégageront de la description qui va suivre en regard des dessins annexés qui ne sont donnés qu'à titre d'exemples non limitatifs.Other features and advantages of the invention will become apparent from the description which follows with reference to the accompanying drawings which are given by way of non-limiting examples.
La figure 1 est une représentation en perspective de l'emballage en position fermée de non-utilisation.Figure 1 is a perspective representation of the packaging in the closed position of non-use.
La figure 2 est une représentation en perspective de l'emballage en position ouverte. La figure 3 est une vue en perspective éclatée représentant les différents composants de l'emballage.Figure 2 is a perspective representation of the packaging in the open position. Figure 3 is an exploded perspective view showing the various components of the package.
Les figures 4, 5, 6 représentent le blister de l'emballage de l'inventionFIGS. 4, 5, 6 show the blister of the package of the invention
La figure 4 est une vue de dessus du blister de l'emballage.Figure 4 is a top view of the blister of the package.
La figure 5 est une vue en coupe selon A-A, du blister de l'emballage.Figure 5 is a sectional view along A-A of the package blister.
La figure 6 est une vue de dessous du blister de l'emballage.Figure 6 is a bottom view of the blister of the package.
Les figures 7 et 8 sont des vues en plan montrant l'emballage dans ses deux positions, sa position initiale de repos (figure 7), et sa position active de prise de médicament (figure 8).Figures 7 and 8 are plan views showing the package in its two positions, its initial rest position (Figure 7), and its active drug-taking position (Figure 8).
Les figures 9, 10, 11, sont des vues en coupe montrant l'emballage dans ses deux positions, sa position initiale de repos (figure 9), et sa position active de prise de médicament (figure 10 et 11).Figures 9, 10, 11 are sectional views showing the package in its two positions, its initial resting position (Figure 9), and its active drug-taking position (Figures 10 and 11).
L'emballage de l'invention portant la référence générale (1) est constitué d'un étui (2), d'un blister (3) et d'un système élastique (4).The packaging of the invention bearing the general reference (1) consists of a case (2), a blister (3) and an elastic system (4).
L'étui (2 ) est par exemple réalisé en carton et est constitué d'une partie que l'on appellera boîtier (5) sur lequel est articulé un rabat, formant couvercle (6).The case (2) is for example made of cardboard and consists of a part that will be called casing (5) on which is articulated a flap, forming a lid (6).
Le boîtier (5), comprend deux trottoirs (7, 8), à savoir un premier trottoir (7) et un deuxième trottoir (8), chacun des trottoirs s' étendant transversalement pour constituer un guidage pour le blister, tandis que le premier trottoir (7) constitue une enceinte de retenue du système élastique (4).The housing (5) comprises two sidewalks (7, 8), namely a first sidewalk (7) and a second sidewalk (8), each sidewalk extending transversely to form a guide for the blister, while the first sidewalk (7) constitutes a retaining enclosure of the elastic system (4).
Le blister (3) est un emballage alvéolaire de distribution de pilules. Il est constitué par un habillage transparent (9) comportant au moins une alvéole (10) fermée par un opercule (11), afin d'emprisonner le comprimé médical (12). Dans le mode de réalisation décrit à titre d'exemple le blister (3) est du type dont l'habillage transparent (9) comprend plusieurs alvéoles (10) et par exemple neufs alvéoles, à savoir trois rangées et trois lignes d'alvéoles.The blister (3) is an alveolar package dispensing pills. It consists of a transparent covering (9) comprising at least one cell (10) closed by a cover (11), in order to trap the medical tablet (12). In the embodiment described by way of example, the blister (3) is of the type whose transparent covering (9) comprises several cells (10) and for example new cells, namely three rows and three rows of cells.
L'habillage transparent est par exemple réalisé de façon connue et notamment par thermoformage d'une feuille par exemple en PVC. Il va de soit que l'habillage (9) pourrait ne pas être transparent, sans pour autant sortir du cadre de l'invention.The transparent covering is for example made in known manner and in particular by thermoforming a sheet, for example PVC. It goes without saying that the covering (9) may not be transparent, without departing from the scope of the invention.
Selon le mode préféré de l'invention le blister (3) comprend par ailleurs une feuille supérieure rigide (13) par exemple en carton, et une feuille inférieure rigide (14) par exemple en carton. Chacune des feuilles de carton comprend des découpes en regard des alvéoles. Les découpes de la feuille supérieure (13) permettent le passage des alvéoles correspondantes (10) de l'habillage transparent (9), tandis que les découpes de la feuille inférieure (14) permettent le passage des comprimés après déformation des alvéoles correspondantes et déchirement de l'opercule (11). Bien entendu le blister ne pourrait comprendre que la feuille inférieure (14) sans pour autant sortir du cadre de l'invention.According to the preferred embodiment of the invention the blister (3) further comprises a rigid upper sheet (13) for example cardboard, and a rigid lower sheet (14) for example cardboard. Each of the sheets of cardboard comprises cutouts facing the cells. The cuts of the upper sheet (13) allow the passage of the corresponding cells (10) of the transparent covering (9), while the cuts of the lower sheet (14) allow the passage of tablets after deformation of the corresponding cells and tearing operculum (11). Of course the blister could only include the lower sheet (14) without departing from the scope of the invention.
Le système élastique (4) est destiné à solliciter le blister (3) en direction du deuxième trottoir (8), et plus particulièrement en appui contre sa paroi verticale (15). Ledit système élastique peut être de tout type, mais selon le mode de réalisation donné à titre d'exemple il est constitué par par un étrier constitué par une lame réalisé en matière plastique déformable, dont les deux branches libres (17a, 17b) sont convergentes. Par ailleurs il est prévu un système de butée (18a, 18b) limitant le pivotement élastique des branches libres (17a, 17b) permettant ainsi un parfait positionnement du blister, dans la position active permettant Ia libération des comprimés. On notera que la paroi constituant le fond (16) de l'étui, comprend une succession de trous permettant le passage des comprimés quand le blister est dans sa position donnant accès aux comprimés. Notons aussi que la paroi de fond (16) à une longueur (Ll) supérieur à la longueur (L2) du blister, et est telle que ladite longueur (Ll) est égale à la longueur (L2) du blister plus la longueur (L4), sachant que la longueur (L4) est légèrement supérieur à la longueur (L3) qui est longueur du système élastique en position sollicitée.The elastic system (4) is intended to urge the blister (3) towards the second sidewalk (8), and more particularly against its vertical wall (15). Said elastic system can be of any type, but according to the embodiment given by way of example it is constituted by a stirrup constituted by a blade made of deformable plastic material, whose two free branches (17a, 17b) are converging . Furthermore there is provided an abutment system (18a, 18b) limiting the elastic pivoting free branches (17a, 17b) thus allowing a perfect positioning of the blister, in the active position for the release of the tablets. Note that the wall constituting the bottom (16) of the case, comprises a succession of holes for the passage of the tablets when the blister is in its position giving access to the tablets. Note also that the bottom wall (16) has a length (L1) greater than the length (L2) of the blister, and is such that said length (L1) is equal to the length (L2) of the blister plus the length (L4 ), knowing that the length (L4) is slightly greater than the length (L3) which is length of the elastic system in the biased position.
On a compris que le blister (3) est mobile et peut se déplacer en translation dans l'étui (2) et ce par coulissement sur le fond (16). Ainsi, le blister peut prendre deux positions, à savoir une position initiale de repos tel qu'illustrée aux figures 7, selon laquelle la position des alvéoles (10) ne correspond pas aux et une position dite active, telle qu'illustrée aux figures 8, 10 et 11, selon laquelle les alvéoles sont une position en correspondance avec les trous (19) de la paroi de fond (16).It is understood that the blister (3) is movable and can move in translation in the case (2) and this by sliding on the bottom (16). Thus, the blister can take two positions, namely an initial rest position as illustrated in FIGS. 7, according to which the position of the cells (10) does not correspond to and a so-called active position, as illustrated in FIGS. , 10 and 11, wherein the cells are a position in correspondence with the holes (19) of the bottom wall (16).
On a compris qu'avec l'emballage de l'invention, pour avoir accès aux comprimés, l'utilisateur doit déplacer le blister afin de mettre en correspondance l'opercule du blister avec le trou de l'étui, et le tenir dans cette position et simultanément pousser sur le comprimé pour l'éjecter. On notera que si l'action sur le blister n'est pas maintenue, ce dernier par l'action d'un système élastique reprend sa position initiale et de ce fait même si l'utilisateur persiste à exercer un effort sur le comprimé, ce dernier ne peut pas être libéré car empêché par le fond de l'étui.It is understood that with the packaging of the invention, to access the tablets, the user must move the blister to match the blister operculum with the hole of the case, and hold it in this position and simultaneously push on the tablet to eject it. Note that if the action on the blister is not maintained, the latter by the action of an elastic system returns to its original position and therefore even if the user persists to exert a force on the tablet, this last can not be released because prevented by the bottom of the holster.
Ce type d'emballage est donc très sécurisant, car un enfant aura du mal à comprendre le processus d'accès aux comprimé et n'arrivera pas à faire les deux actions simultanément. 54This type of packaging is very safe, because a child will have difficulty understanding the process of access to the tablet and will not be able to do both actions simultaneously. 54
L'emballage selon l'invention comprend des moyens de préhension (20) mettant à l'utilisateur de déplacer le blister. Ces moyens peuvent être de out genre, comme par exemple une saillie disposée sur le dessus du blister. Ces moyens peuvent être aussi tel que cela est illustré, à savoir, un trou (20a) réalisé dans Ia paroi du blister et un trou oblong correspondant (20b) réalisé sur la paroi de fond (16) de l'étui.The package according to the invention comprises gripping means (20) for the user to move the blister. These means can be of any kind, such as for example a projection disposed on the top of the blister. These means may also be as illustrated, namely, a hole (20a) formed in the wall of the blister and a corresponding oblong hole (20b) formed on the bottom wall (16) of the case.
Notons aussi que grâce à l'emballage de l'invention, qu'à l'état de repos en position initial donc du blister, l'opercule en aluminium n'est pas visible car caché par la paroi de fond de l'étui, même si l'étui est ouvert.Note also that thanks to the packaging of the invention, that the state of rest in the initial position therefore the blister, the aluminum cover is not visible because hidden by the bottom wall of the case, even if the case is open.
Bien entendu, l'invention n'est pas limitée aux modes de réalisation décrits et représentés à titre d'exemples, mais elle comprend aussi tous les équivalents techniques ainsi que leurs combinaisons. Of course, the invention is not limited to the embodiments described and represented by way of examples, but it also includes all the technical equivalents as well as their combinations.

Claims

REVENDICATIONS
1. Emballage (1) sécurisé pour médicaments (12), caractérisé en ce qu'il comprend des moyens de condamnation d'accès au médicament tels que pour accéder aux médicaments l'utilisateur doit exécuter deux actions simultanées, tandis que dès qu'une des actions est interrompue l'accès est rendu impossible.1. Packing (1) secure for drugs (12), characterized in that it comprises means of condemnation of access to the drug such as to access the drugs the user must perform two simultaneous actions, while as soon as a actions is interrupted access is made impossible.
2. Emballage (1) sécurisé pour médicaments (12) selon la revendication 1, caractérisé en ce qu'il est constitué d'un étui (2), d'un blister (3) et d'un système élastique (4).2. Packaging (1) secure drug (12) according to claim 1, characterized in that it consists of a case (2), a blister (3) and an elastic system (4).
3. Emballage (1) sécurisé pour médicaments (12) selon la revendication 2, caractérisé en ce que le blister (3) est un emballage alvéolaire de distribution de pilules.3. Packaging (1) secure drug (12) according to claim 2, characterized in that the blister (3) is a cellular package dispensing pills.
4. Emballage (1) sécurisé pour médicaments (12) selon la revendication4. Packaging (1) secure for drugs (12) according to the claim
3, caractérisé en ce que le blister (3) est constitué par un habillage transparent (9) comportant au moins une alvéole (10) fermée par un opercule (11), afin d'emprisonner le comprimé médical (12).3, characterized in that the blister (3) is constituted by a transparent covering (9) comprising at least one cell (10) closed by a cover (11), in order to trap the medical tablet (12).
5. Emballage (1) sécurisé pour médicaments (12) selon la revendication5. Packaging (1) secure for drugs (12) according to the claim
4, caractérisé en ce que l'étui (2 ) est constitué d'une partie que l'on appellera boîtier (5) sur lequel est articulé un rabat, formant couvercle (6).4, characterized in that the case (2) consists of a part which will be called casing (5) on which is articulated a flap, forming a lid (6).
6. Emballage (1) sécurisé pour médicaments (12) selon la revendication 5, caractérisé en ce que le boîtier (5), comprend deux trottoirs (7, 8), à savoir un premier trottoir (7) et un deuxième trottoir (8), chacun des trottoirs s' étendant transversalement pour constituer un guidage pour le blister, tandis que le premier trottoir (7) constitue une enceinte de retenue du système élastique (4).6. Packaging (1) secure medication (12) according to claim 5, characterized in that the housing (5) comprises two sidewalks (7, 8), namely a first sidewalk (7) and a second sidewalk (8). ), each sidewalk extending transversely to form a guide for the blister, while the first sidewalk (7) constitutes a retaining enclosure of the elastic system (4).
7. Emballage (1) sécurisé pour médicaments (12) selon l'une quelconque des revendications 2 à 6, caractérisé en ce que la paroi constituant le fond (16) de l'étui, comprend au moins un trou permettant le passage des médicaments quand le blister est dans sa position donnant accès aux médicaments.7. Packaging (1) for secure medicines (12) according to any one of claims 2 to 6, characterized in that the wall constituting the bottom (16) of the case, includes at least one hole allowing the passage of drugs when the blister is in its position giving access to drugs.
8. Emballage (1) sécurisé pour médicaments (12) selon l'une quelconque des revendications 2 à 7, caractérisé en ce que le blister (3) comprend au moins une feuille inférieure (14) rigide comprenant des découpes destinées à être en regard des alvéoles, afin de permettre le passage des comprimés après déformation des alvéoles correspondantes et déchirement de l'opercule (11).8. Packaging (1) secure for drugs (12) according to any one of claims 2 to 7, characterized in that the blister (3) comprises at least one lower sheet (14) comprising rigid cutouts intended to be opposite cells, to allow the passage of the tablets after deformation of the corresponding cells and tearing of the lid (11).
9. Emballage (1) sécurisé pour médicaments (12) selon l'une quelconque des revendications 2 à 8, caractérisé en ce le blister (3) est monté mobile dans l'étui, et peut ainsi se déplacer en translation dans l'étui (2) et ce par coulissement sur le fond (16) pour prendre deux positions, à savoir une position initiale de repos, selon laquelle la position des alvéoles (10) ne correspond pas aux trous (19) formes dans la paroi de fond et une position dite active, selon laquelle les alvéoles sont dans une position en correspondance avec les trous (19) de la paroi de fond (16).9. Packaging (1) secure medication (12) according to any one of claims 2 to 8, characterized in that the blister (3) is movably mounted in the case, and can move in translation in the case (2) and by sliding on the bottom (16) to take two positions, namely an initial position of rest, in which the position of the cells (10) does not correspond to the holes (19) formed in the bottom wall and a so-called active position, in which the cells are in a position corresponding to the holes (19) of the bottom wall (16).
10. Emballage (1) sécurisé pour médicaments (12) selon la revendication précédente, caractérisé en ce que le système élastique (4) est destiné à solliciter le blister (3) en direction du deuxième trottoir (8), et plus particulièrement en appui contre sa paroi verticale (15). 10. Packaging (1) secure medication (12) according to the preceding claim, characterized in that the elastic system (4) is intended to urge the blister (3) towards the second sidewalk (8), and more particularly in support against its vertical wall (15).
EP06830974A 2005-10-25 2006-10-18 Secure tablet package Not-in-force EP1945532B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0510884A FR2892398B1 (en) 2005-10-25 2005-10-25 SECURE PACKAGING FOR COMPRESS
PCT/FR2006/002354 WO2007048906A1 (en) 2005-10-25 2006-10-18 Secure tablet package

Publications (2)

Publication Number Publication Date
EP1945532A1 true EP1945532A1 (en) 2008-07-23
EP1945532B1 EP1945532B1 (en) 2011-06-08

Family

ID=36716826

Family Applications (1)

Application Number Title Priority Date Filing Date
EP06830974A Not-in-force EP1945532B1 (en) 2005-10-25 2006-10-18 Secure tablet package

Country Status (6)

Country Link
US (1) US8746454B2 (en)
EP (1) EP1945532B1 (en)
AT (1) ATE512092T1 (en)
CA (1) CA2626276A1 (en)
FR (1) FR2892398B1 (en)
WO (1) WO2007048906A1 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9150119B2 (en) 2013-03-15 2015-10-06 Aesynt Incorporated Apparatuses, systems, and methods for anticipating and delivering medications from a central pharmacy to a patient using a track based transport system
US9511945B2 (en) 2012-10-12 2016-12-06 Aesynt Incorporated Apparatuses, systems, and methods for transporting medications from a central pharmacy to a patient in a healthcare facility

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090283439A1 (en) * 2008-05-15 2009-11-19 Catalent Pharma Solutions Trigger lock for pill calendar
EP2216266A1 (en) 2009-02-06 2010-08-11 Novartis AG Multiple-use dispenser for articles contained in blister-type packages
USD731783S1 (en) 2014-04-16 2015-06-16 Abbvie Inc. Template for a prescription medicine container
USD731782S1 (en) 2013-10-07 2015-06-16 Abbvie Inc. Template for a prescription medicine container
USD731171S1 (en) 2013-10-07 2015-06-09 Abbvie Inc. Template for a prescription medicine container
EP3142590B1 (en) * 2014-05-16 2020-05-13 Smith & Nephew plc Reduced pressure wound therapy kit and packaging
GB2530587A (en) * 2014-11-03 2016-03-30 Multi Packaging Solutions Uk Ltd Packaging
AU2016201131B2 (en) * 2015-03-30 2020-04-02 Manrex Limited Dispensing container for blister pack of medication
USD831330S1 (en) * 2015-10-19 2018-10-23 Abbvie Inc. Medication packaging combined with dispensing container
US10206851B1 (en) * 2017-10-05 2019-02-19 Andersonbrecon Inc. Child-resistant, senior-friendly package
FR3072952B1 (en) * 2017-10-26 2020-11-06 A C D Agence Commerciale Doucet SECURE PACKAGING FOR TABLETS
USD930973S1 (en) * 2018-03-22 2021-09-21 Abbvie Inc. Child-resistant medication container
US11052021B2 (en) * 2018-03-22 2021-07-06 Abbvie Inc. Medicine container, method of assembling the container, and method of dispensing the medicine from the container
USD930974S1 (en) * 2018-03-22 2021-09-21 Abbvie Inc. Child-resistant medication container
USD882243S1 (en) 2018-03-26 2020-04-28 Abbvie Inc. Child-resistant medication container assembly
EP3696113A1 (en) * 2019-02-13 2020-08-19 Innorese AG Child-proof packaging
WO2022219707A1 (en) * 2021-04-13 2022-10-20 日本たばこ産業株式会社 Package

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3324996A (en) * 1966-01-19 1967-06-13 Searle & Co Dispenser for pharmaceutical tablets
US5150793A (en) * 1991-10-16 1992-09-29 Pci/Delvco, Inc. Device for inhibiting removal of an article from a blister-type container
GB9713876D0 (en) * 1997-06-30 1997-09-03 Glaxo Group Ltd Device for holding blister pack
DE59904850D1 (en) * 1999-06-02 2003-05-08 Alcan Tech & Man Ag Blister pack
EP1057750B1 (en) * 1999-06-02 2003-03-26 Alcan Technology & Management AG Child-resistant package for tablets
US6832686B2 (en) * 2001-03-20 2004-12-21 Michael Patrick Donegan Child resistant compact case
DE10117910C1 (en) * 2001-04-10 2002-08-22 Udo Simon Drug container with child lock
GB0116351D0 (en) * 2001-07-05 2001-08-29 Ads Graphics Ltd Childproof blister packaging
US6863175B2 (en) * 2001-07-18 2005-03-08 Meadwestvaco Corporation Locking container
US6540081B2 (en) * 2001-09-06 2003-04-01 Ecolab Inc. Unit dose blister pack product dispenser
GB2388836A (en) * 2001-11-15 2003-11-26 Team Holdings A dispensing device
US6726015B2 (en) * 2002-04-01 2004-04-27 Sharp Corporation Medicant package
US6726053B1 (en) * 2002-10-29 2004-04-27 John E. Harrold Child resistant multiple dosage blister pack dispenser
GB0228983D0 (en) * 2002-12-12 2003-01-15 Mso Cleland Ltd A device for containing a blister pack
DE10307590B4 (en) * 2003-02-22 2007-05-10 Uhlmann Pac-Systeme Gmbh & Co Kg Child-safe blister pack
JP4299035B2 (en) * 2003-03-31 2009-07-22 朝日印刷株式会社 Package for PTP sheet
US6988618B2 (en) * 2004-01-26 2006-01-24 Dejonge Associates, Inc. Child resistant blister pack dispenser with locking side tabs
US7370773B2 (en) * 2004-12-21 2008-05-13 Mcneil-Ppc, Inc. Child-resistant closure for dispensing containers

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See references of WO2007048906A1 *

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9511945B2 (en) 2012-10-12 2016-12-06 Aesynt Incorporated Apparatuses, systems, and methods for transporting medications from a central pharmacy to a patient in a healthcare facility
US10029856B2 (en) 2012-10-12 2018-07-24 Aesynt Incorporated Apparatuses, systems, and methods for transporting medications from a central pharmacy to a patient in a healthcare facility
US10315851B2 (en) 2012-10-12 2019-06-11 Aesynt Incorporated Apparatuses, systems, and methods for transporting medications from a central pharmacy to a patient in a healthcare facility
US10518981B2 (en) 2012-10-12 2019-12-31 Aesynt Incorporated Apparatuses, systems, and methods for transporting medications from a central pharmacy to a patient in a healthcare facility
US10850926B2 (en) 2012-10-12 2020-12-01 Omnicell, Inc. Apparatuses, systems, and methods for transporting medications from a central pharmacy to a patient in a healthcare facility
US11694782B2 (en) 2012-10-12 2023-07-04 Omnicell, Inc. Apparatuses, systems, and methods for transporting medications from a central pharmacy to a patient in a healthcare facility
US9150119B2 (en) 2013-03-15 2015-10-06 Aesynt Incorporated Apparatuses, systems, and methods for anticipating and delivering medications from a central pharmacy to a patient using a track based transport system

Also Published As

Publication number Publication date
ATE512092T1 (en) 2011-06-15
WO2007048906A1 (en) 2007-05-03
US8746454B2 (en) 2014-06-10
FR2892398B1 (en) 2010-04-23
CA2626276A1 (en) 2007-05-03
FR2892398A1 (en) 2007-04-27
EP1945532B1 (en) 2011-06-08
US20090038982A1 (en) 2009-02-12

Similar Documents

Publication Publication Date Title
EP1945532B1 (en) Secure tablet package
EP1833741B1 (en) Device for storing and dispensing in single-units objects in the form of sheets or thin strips
EP3016880B1 (en) Packaging enclosing lozenge products and blank for obtaining said packaging
EP1554191A1 (en) Rigid plastic protective case for a blister pack
EP1216928A1 (en) Device for storing and applying a liquid product
WO1998038109A1 (en) Packaging assembly comprising a shell sealed by blister pack
EP2336045A1 (en) Dispenser housing for tablets
WO2004016521A1 (en) Dispensing device for fluid product
EP0859725B1 (en) Device for dispensing lozenges and capsules
FR3105189A1 (en) Bulk product gravity flow dispenser
FR2791321A1 (en) PACKAGING IN SEMI-RIGID MATERIAL, COMPRISING A BODY AND A PIVOTING MOUNTED PART FORMING A CLOSABLE COVER
FR2638430A3 (en) Packaging for prepacked pharmaceutical products of the tablet, capsule, lozenge or similar type
FR2558697A2 (en) Souvenir device capable, moreover, of dispensing a perfume, a deodorant or the like
FR2678584A1 (en) Package made of plastic material, formed from two assembled symmetrical shells
FR2753174A1 (en) Carton opener design especially for food cartons
EP0509896A1 (en) Disposable package case, in particular for a refill of a cosmetic product
EP0857665A1 (en) Dispensing package for stored articles and products
FR2478591A1 (en) Child resistant box for medicinal pills etc. - incorporating sachet grid and outlet chicane walls of moulded plastics or alloy
EP1409367A1 (en) Fluid product dispensing assembly
FR2929602A1 (en) Food product e.g. foie gras, extracting device for animal nutrition field, has tabs articulated at support part along articulation line merged with periphery of support part, where device is made from single piece by cutting sheet material
FR2809383A1 (en) DEVICE FOR DISPENSING / DECOVERING INDIVIDUALLY PACKAGED PRODUCTS
EP2230187B1 (en) Transparent box with hinged lid stiffened by an inner band
FR3121130A3 (en) Packaging for hybrid food product
FR2723917A1 (en) Earthenware vessel for containing sliceable food
FR2915464A1 (en) Article packaging and distributing package for commercial area, has lower part with reinforcement and stopping units arranged to rigidify lower part in inclined position and to limit inclination angle

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20080416

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR

17Q First examination report despatched

Effective date: 20081008

GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

DAX Request for extension of the european patent (deleted)
GRAS Grant fee paid

Free format text: ORIGINAL CODE: EPIDOSNIGR3

GRAA (expected) grant

Free format text: ORIGINAL CODE: 0009210

AK Designated contracting states

Kind code of ref document: B1

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR

REG Reference to a national code

Ref country code: GB

Ref legal event code: FG4D

Free format text: NOT ENGLISH

REG Reference to a national code

Ref country code: CH

Ref legal event code: EP

REG Reference to a national code

Ref country code: IE

Ref legal event code: FG4D

Free format text: LANGUAGE OF EP DOCUMENT: FRENCH

REG Reference to a national code

Ref country code: DE

Ref legal event code: R096

Ref document number: 602006022433

Country of ref document: DE

Effective date: 20110721

REG Reference to a national code

Ref country code: NL

Ref legal event code: VDEP

Effective date: 20110608

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20110608

Ref country code: LT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20110608

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SI

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20110608

Ref country code: LV

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20110608

Ref country code: FI

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20110608

Ref country code: CY

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20110608

Ref country code: GR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20110909

Ref country code: AT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20110608

Ref country code: ES

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20110919

REG Reference to a national code

Ref country code: CH

Ref legal event code: NV

Representative=s name: AMMANN PATENTANWAELTE AG BERN

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: NL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20110608

REG Reference to a national code

Ref country code: IE

Ref legal event code: FD4D

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: CZ

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20110608

Ref country code: PT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20111010

Ref country code: IS

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20111008

Ref country code: IE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20110608

Ref country code: EE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20110608

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: RO

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20110608

Ref country code: SK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20110608

Ref country code: PL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20110608

PLBE No opposition filed within time limit

Free format text: ORIGINAL CODE: 0009261

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT

BERE Be: lapsed

Owner name: ACD

Effective date: 20111031

26N No opposition filed

Effective date: 20120309

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: MC

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20111031

Ref country code: IT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20110608

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: DK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20110608

REG Reference to a national code

Ref country code: DE

Ref legal event code: R097

Ref document number: 602006022433

Country of ref document: DE

Effective date: 20120309

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: BE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20111031

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: LU

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20111018

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: BG

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20110908

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: TR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20110608

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: HU

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20110608

REG Reference to a national code

Ref country code: FR

Ref legal event code: PLFP

Year of fee payment: 10

REG Reference to a national code

Ref country code: FR

Ref legal event code: PLFP

Year of fee payment: 11

REG Reference to a national code

Ref country code: FR

Ref legal event code: PLFP

Year of fee payment: 12

REG Reference to a national code

Ref country code: FR

Ref legal event code: PLFP

Year of fee payment: 13

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: DE

Payment date: 20191021

Year of fee payment: 14

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: FR

Payment date: 20191025

Year of fee payment: 14

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: CH

Payment date: 20191029

Year of fee payment: 14

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: GB

Payment date: 20191003

Year of fee payment: 14

REG Reference to a national code

Ref country code: DE

Ref legal event code: R119

Ref document number: 602006022433

Country of ref document: DE

REG Reference to a national code

Ref country code: CH

Ref legal event code: PL

GBPC Gb: european patent ceased through non-payment of renewal fee

Effective date: 20201018

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: DE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20210501

Ref country code: FR

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20201031

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: CH

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20201031

Ref country code: LI

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20201031

Ref country code: GB

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20201018